BioInvent International
Sweden - LundBiotechnology
Focus: BioInvent International is a Swedish public biotech company founded in 1988 specializing in antibody-based drugs targeting oncology and cardiovascular diseases. The company operates as a focused mid-cap biotech with a diversified pipeline in early-to-mid stage clinical development.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About BioInvent International
AI assessmentNot HiringNo open roles listed right now. Follow BioInvent International to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
19 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MLDL1278A
HealthyTB-403
Solid TumorsAdministration of recombinant FVIII/placebo in healthy male subjects treated with TB-402
Help build intelligence for BioInvent International
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.